CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS - RESULTS FROM REPURPSS-I
DSpace/Manakin Repository
CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS - RESULTS FROM REPURPSS-I
Van Roon, Joel; van der Heijden, Eefje; Blokland, Sofie; Lopes, Ana; Moret, Frederique; Welsing, Paco; Janssen, Nard; Rosenberg, Toine; Pandit, Aridaman; Tao, Weiyang; Hillen, Maarten; Kruize, Aike A.; Radstake, Timothy R.
(2019) Annals of the Rheumatic Diseases, volume 78, issue Suppl 2, pp. 396 - 396
(Abstract)
Download/Full Text
The full text of this publication is not available.